Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 26% ± 6% | |
retinal cone cell | 6 studies | 25% ± 7% | |
astrocyte | 5 studies | 37% ± 11% | |
plasma cell | 4 studies | 25% ± 7% | |
epithelial cell | 4 studies | 31% ± 9% | |
adipocyte | 4 studies | 17% ± 1% | |
retinal rod cell | 4 studies | 25% ± 5% | |
GABAergic neuron | 4 studies | 43% ± 18% | |
macrophage | 4 studies | 21% ± 3% | |
ciliated cell | 3 studies | 19% ± 0% | |
glutamatergic neuron | 3 studies | 61% ± 5% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 3% | |
interneuron | 3 studies | 45% ± 23% | |
oligodendrocyte | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2482.66 | 1445 / 1445 | 100% | 16.16 | 183 / 183 |
prostate | 100% | 2623.89 | 245 / 245 | 100% | 12.50 | 502 / 502 |
stomach | 100% | 1820.76 | 359 / 359 | 100% | 12.91 | 286 / 286 |
breast | 100% | 1888.16 | 459 / 459 | 100% | 13.35 | 1116 / 1118 |
thymus | 100% | 2204.13 | 653 / 653 | 100% | 9.20 | 602 / 605 |
intestine | 100% | 2212.02 | 966 / 966 | 99% | 11.01 | 524 / 527 |
bladder | 100% | 2580.62 | 21 / 21 | 99% | 9.31 | 501 / 504 |
uterus | 100% | 2117.82 | 170 / 170 | 99% | 8.02 | 455 / 459 |
lung | 99% | 1849.57 | 572 / 578 | 100% | 11.12 | 1155 / 1155 |
pancreas | 100% | 1915.38 | 328 / 328 | 99% | 7.92 | 176 / 178 |
ovary | 100% | 1501.14 | 180 / 180 | 99% | 6.49 | 424 / 430 |
liver | 100% | 1642.07 | 225 / 226 | 99% | 6.52 | 402 / 406 |
kidney | 100% | 1408.53 | 89 / 89 | 96% | 7.17 | 869 / 901 |
skin | 100% | 7576.71 | 1809 / 1809 | 94% | 6.85 | 443 / 472 |
brain | 91% | 900.36 | 2407 / 2642 | 99% | 4.79 | 697 / 705 |
adrenal gland | 100% | 2833.95 | 258 / 258 | 79% | 3.83 | 181 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.50 | 29 / 29 |
muscle | 100% | 4909.27 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1715.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.40 | 1 / 1 |
adipose | 100% | 1935.48 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2121.44 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 1980.64 | 814 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 4.90 | 66 / 80 |
peripheral blood | 58% | 978.31 | 542 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010815 | Biological process | bradykinin catabolic process |
GO_0050435 | Biological process | amyloid-beta metabolic process |
GO_0019885 | Biological process | antigen processing and presentation of endogenous peptide antigen via MHC class I |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0010992 | Biological process | ubiquitin recycling |
GO_0042447 | Biological process | hormone catabolic process |
GO_0097242 | Biological process | amyloid-beta clearance |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0006508 | Biological process | proteolysis |
GO_0150094 | Biological process | amyloid-beta clearance by cellular catabolic process |
GO_1901142 | Biological process | insulin metabolic process |
GO_0030163 | Biological process | protein catabolic process |
GO_1901143 | Biological process | insulin catabolic process |
GO_1903715 | Biological process | regulation of aerobic respiration |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0043171 | Biological process | peptide catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005777 | Cellular component | peroxisome |
GO_0009986 | Cellular component | cell surface |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0042277 | Molecular function | peptide binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0043559 | Molecular function | insulin binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | IDE |
Protein name | Insulin degrading enzyme Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) Insulin degrading enzyme (cDNA FLJ35968 fis, clone TESTI2013053, highly similar to INSULIN-DEGRADING ENZYME) |
Synonyms | |
Description | FUNCTION: Plays a role in the cellular breakdown of insulin, APP peptides, IAPP peptides, natriuretic peptides, glucagon, bradykinin, kallidin, and other peptides, and thereby plays a role in intercellular peptide signaling . Substrate binding induces important conformation changes, making it possible to bind and degrade larger substrates, such as insulin . Contributes to the regulation of peptide hormone signaling cascades and regulation of blood glucose homeostasis via its role in the degradation of insulin, glucagon and IAPP (By similarity). Plays a role in the degradation and clearance of APP-derived amyloidogenic peptides that are secreted by neurons and microglia (Probable). Degrades the natriuretic peptides ANP, BNP and CNP, inactivating their ability to raise intracellular cGMP . Also degrades an aberrant frameshifted 40-residue form of NPPA (fsNPPA) which is associated with familial atrial fibrillation in heterozygous patients . Involved in antigen processing. Produces both the N terminus and the C terminus of MAGEA3-derived antigenic peptide (EVDPIGHLY) that is presented to cytotoxic T lymphocytes by MHC class I. .; FUNCTION: (Microbial infection) The membrane-associated isoform acts as an entry receptor for varicella-zoster virus (VZV). . |
Accessions | ENST00000677434.1 R4GN65 P14735 A0A7I2V2P6 ENST00000678824.1 A0A7I2V4A4 ENST00000679089.1 ENST00000650060.2 A0A7I2V4Q3 A0A7I2YQV5 ENST00000676540.1 A0A3B3ISG5 ENST00000678844.1 A0A7I2V2S1 A0A7I2V3E3 A0A7I2V373 A0A7I2V610 ENST00000677079.1 A0A7I2V612 ENST00000478361.6 ENST00000677096.1 ENST00000679222.1 ENST00000679232.1 A0A7I2V634 ENST00000496903.5 ENST00000679312.1 ENST00000371581.9 [P14735-2] ENST00000265986.11 [P14735-1] ENST00000678673.1 A0A7I2YQS6 ENST00000679174.1 ENST00000676816.1 ENST00000677569.1 ENST00000677978.1 ENST00000678715.1 A0A7I2V3K9 B3KSB8 |